Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Cannabis Bioscience International Holdings (CBIH) Total Liabilities (2022 - 2025)

Cannabis Bioscience International Holdings' Total Liabilities history spans 4 years, with the latest figure at $1.4 million for Q4 2025.

  • For Q4 2025, Total Liabilities rose 15.48% year-over-year to $1.4 million; the TTM value through Nov 2025 reached $1.4 million, up 15.48%, while the annual FY2025 figure was $1.2 million, 5.22% up from the prior year.
  • Total Liabilities for Q4 2025 was $1.4 million at Cannabis Bioscience International Holdings, up from $1.3 million in the prior quarter.
  • Across five years, Total Liabilities topped out at $1.4 million in Q4 2025 and bottomed at $405301.0 in Q4 2022.
  • The 4-year median for Total Liabilities is $1.1 million (2024), against an average of $982850.8.
  • The largest annual shift saw Total Liabilities soared 132.85% in 2023 before it rose 5.22% in 2025.
  • A 4-year view of Total Liabilities shows it stood at $405301.0 in 2022, then skyrocketed by 132.85% to $943726.0 in 2023, then increased by 27.11% to $1.2 million in 2024, then grew by 15.48% to $1.4 million in 2025.
  • Per Business Quant, the three most recent readings for CBIH's Total Liabilities are $1.4 million (Q4 2025), $1.3 million (Q3 2025), and $1.2 million (Q2 2025).